Dyslipidemia
Not recommended
Spirulina is an over-the-counter supplement. The Huang meta-analysis (J Clin Lipidol 2018) pooled 12 RCTs with 887 participants: at 1–10 g/day for 2–12 months in patients with dyslipidaemia, spirulina lowered total cholesterol by a mean 0.8 mmol/L and by 0.5 mmol/L versus placebo. The effect is smaller than with statins, methodology heterogeneous and risk of bias high. 2019 and Spanish SEA 2022 standards recommend statins as first line in confirmed cardiovascular risk plus lifestyle change (Mediterranean diet, physical activity, smoking cessation). Spirulina is not in international or Spanish guidelines. If spirulina was bought instead of a prescribed statin, discuss with a cardiologist; stopping a statin in confirmed coronary disease multiplies the heart-attack risk.
Sources
- J Clin Lipidol (Huang et al.): Effects of spirulina supplementation on lipid profile: a systematic review and meta-analysis of RCTs (2018)
- ESC/EAS: ESC/EAS Guidelines for the management of dyslipidaemias (2019)
- SEA: Sociedad Española de Arteriosclerosis: estandares para el control lipidico (2022)
- EFSA NDA Panel: Scientific Opinion on the substantiation of health claims related to Spirulina (2009)